|March 8, 2007 | Dallas, Texas
March 21, 2007 | Philadelphia, PA
April 13, 2007 | San Francisco, CA
"In partnership with the Assistant Secretary of Health and the Regional Health Administrators of the Department of Health and Human Services (HHS), ASTHO held three regional Roundtables during the months of March and April 2007. The goal of the Roundtables was to provide a structured forum to advance discussions, debates and exchange of opinions and ideas on complex
key elements associated with pandemic influenza preparedness, with a special emphasis on regional and cross-border challenges. These Roundtables also provided a means to enrich the participants' understanding of the various challenges and approaches to improving pandemic preparedness, policy development, and response coordination. Through this process, specific follow-up actions were also identified for consideration by ASTHO, the federal government, or others to close policy gaps in order to strengthen our collective capacity to prepare for and manage the consequences of an influenza pandemic.
The topics discussed were: Community Mitigation Strategies, Antiviral Management and Administration, Vaccine Prioritization, and the Implementation of the Pandemic and All Hazards Preparedness Act. In addition, informal discussions were held on the feasibility of pursuing shelf-life extension status for state owned and managed caches of antivirals the current shelf-life extension program (SLEP) is only available to pharmaceutical assets held by three federal agencies.
In all, approximately 200 public health leaders attended the Roundtables. This included principally State and Territorial Health Officials, Senior Deputies, Medical Directors and Directors of Public Health Preparedness; HHS Regional Health Administrators, Regional Directors and Regional Emergency Coordinators; tribal and local health officials; as well as subject matter experts and decision leaders from the Office of the HHS Assistant Secretary for Preparedness and Response, Centers for Disease Control and Prevention, National Vaccine Program Office, Indian Health Service, Department of Homeland Security and Department of Defense."